Skip to main content

Closed

NVO: Novo Nordisk A/S Financial Statements & Revenue | finqOS

Healthcare · Drug Manufacturers - General

52W Range

41thpctl

Volume

2.01×avg

Market Cap

209.19BUSD

P/E Ratio

11.2TTM

Div Yield

3.82%ann

Novo Nordisk A/S

NVONew York Stock Exchange·USD·Closed

Novo Nordisk A/S

NVONew York Stock Exchange·USD·Closed

$47.08

−8.79%

$47.08

−$4.53 (8.79%)

52W Range

41thpctl

Volume

2.01×avg

Mkt Cap

209.19BUSD

P/E

11.2TTM

Div Yield

3.82%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings